Showing 421 - 440 results of 99,181 for search '(( 50 ms decrease ) OR ( 5 ((wt decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 1.39s Refine Results
  1. 421

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM—5.0 mM. …”
  2. 422
  3. 423
  4. 424

    Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding. by Erik van Kampen (649704)

    Published 2014
    “…After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be measured. No difference was observed after 6 weeks of dietary challenge. …”
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430

    Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

    Published 2015
    “…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”
  11. 431
  12. 432
  13. 433

    Heat inactivation curves for the WT SULT1A1 protein and the 5C2, 5F8 and D249G SULT1A1 mutants. by Ilana Berger (198531)

    Published 2011
    “…The decrease in stability of the 5F8 mutant, relative to 1E8, and the D249G mutant, relative to the WT protein, highlight the trade-off between thermostability and the acquisition of new catalytic properties (see text for details).…”
  14. 434
  15. 435
  16. 436

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”
  17. 437
  18. 438
  19. 439
  20. 440

    PM exposure affects small airways to a greater degree in WT compared to Ager<sup>-/-</sup> mice. by Erin J. Caraher (4445902)

    Published 2017
    “…<p>(A) WT-PM mice had significantly elevated tissue resistance at 1Hz p<0.001 (*). …”